https://regulatorynews.com/e2-helo-return-fda-clearance Regulatory News en 2026-10-16T09:53:32-04:00 E2 Clears FDA Hurdle for Blood-Saving Clot Device https://regulatorynews.com/iambic-therapeutics-nasdaq-ipo Regulatory News en 2026-10-16T09:53:32-04:00 Iambic Prices $150M IPO to Fund AI-Built Cancer Drug https://regulatorynews.com/souffle-therapeutics-series-b-financing Regulatory News en 2026-10-16T09:53:32-04:00 Soufflé Raises $135M to Push RNA Drug Into the Clinic https://regulatorynews.com/fyb206-keytruda-biosimilar-bla Regulatory News en 2026-10-16T05:57:35-04:00 FDA Accepts First Keytruda Biosimilar for Review https://regulatorynews.com/mhra-strategy-2030 Regulatory News en 2026-10-16T05:57:35-04:00 MHRA Publishes Strategy 2030 for the AI Era https://regulatorynews.com/olympus-fda-warning-letter Regulatory News en 2026-10-16T05:57:35-04:00 Olympus Discloses New FDA Warning Letter Over QMS